Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

SENS Research Foundation founder accused of sexual harassment

The co-founder of the organization, Aubrey de Grey, denies the allegations. An independent investigation is underway.

By Brian Buntz | August 12, 2021

SENS Research FoundationThe SENS Research Foundation (Mountain View, Calif.), an anti-aging and regenerative medicine nonprofit, has placed the prominent biogerontologist Aubrey de Grey on leave following sexual harassment allegations. The foundation has also retained an independent investigator to review the claims.

The accusations come from Celine Halioua, the CEO of veterinary biotech Loyal (San Francisco) and Laura Deming, the founder of the Longevity Fund (San Francisco).

Halioua and Deming have described their allegations on personal websites. Halioua calls him a “sexual predator,” while Deming reports that de Grey harassed her when she was a minor.

In a Facebook post, de Grey denied the allegations. De Grey stated that the two women “have been deceived into the view that [he has] done many things that [he has] in fact not done.” He continues to theorize that Halioua and Deming “have been set up.”

De Grey vowed if evidence emerges supporting the sexual harassment claims, he will “step aside a great deal faster than [former N.Y. governor Andrew] Cuomo just did.”

Until recently, de Grey had been a notable figure in gerontology and other fields. Known for making outlandish claims, de Grey predicted that the first person to live past the age of 1,000 may already be alive. He also contributed to advancing mathematics related to the Hadwiger–Nelson problem in geometric graph theory.

De Grey is also the vice president of new technology discovery at AgeX Therapeutics (Alameda, Calif.)

Grey also co-founded the nonprofit Methuselah Foundation (Springfield, Va.) in 2003. The organization includes the subsidiary the Methuselah Foundation, which invests in anti-aging startups. Funding recipients of the Methuselah Foundation include 3D bioprinting firm Organovo, Oisin Biotechnologies and Leucadia Therapeutics.


Filed Under: Drug Discovery, Drug Discovery and Development
Tagged With: AgeX Therapeutics, Aubrey de Grey, ENS Research Foundation, gerontology, SENS Research Foundation, sexual harassment
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

lab microscope
Accelerating R&D with FAIR data
Kallyope
Kallyope’s focus on the gut-brain axis yields a diverse portfolio
Axcella
Axcella touts positive results from Phase 2a long COVID study
artificial intelligence
Defining complexity: A framework to identify complex clinical trials and set them up for success

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50